An open-label randomized active-controlled phase II clinical study to assess the efficacy and safety of afuresertib plus paclitaxel versus paclitaxel in patients with platinum-resistant ovarian cancer (PROFECTA-II/GOG-3044)

Authors:

Abstract
No abstract available
Funding Information
  • GOG Foundation

This publication has 23 references indexed in Scilit: